Specifically, the KDM5B/LSD1/NuRD complex binds to the CCL14 promoter and suppresses its transcription by reducing H3K4 methylation levels, thus effectively inhibiting the invasive ability of BC cells and angiogenesis in vivo. The gene discussed is KDM5B; the disease is breast cancer.